Utility of Ki67 labeling index, cyclin D1 expression, and ER-activity level in postmenopausal ER-positive and HER2-negative breast cancer with neoadjuvant chemo-endocrine therapy

In this study, we investigated the relationships of pathological response after neoadjuvant chemo-endocrine therapy with alterations in the Ki67 labeling index (LI), expression of cyclin D1 (CCND1) and progesterone receptor (PgR), and estrogen receptor (ER) activity in breast cancer. A total of 43 J...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurozumi, Sasagu, Yamaguchi, Yuri, Matsumoto, Hiroshi, Kurosumi, Masafumi, Hayashi, Shin-ichi, Fujii, Takaaki, Horiguchi, Jun, Shirabe, Ken, Inoue, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528995/
https://www.ncbi.nlm.nih.gov/pubmed/31112577
http://dx.doi.org/10.1371/journal.pone.0217279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528995/
https://www.ncbi.nlm.nih.gov/pubmed/31112577
http://dx.doi.org/10.1371/journal.pone.0217279

Ejemplares similares